新兴的纳米酶策略用于精确治疗乳腺癌
Jian Zang1, Zhaozhou Ren2, Haibo Wang1
1The first Hospital of China Medical University, Liaoning, 110001, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|October 27, 2025
概括
纳米酶通过增强免疫疗法和化疗,为乳腺癌提供了新的精确治疗方法. 这些纳米材料在组合疗法中也显示出前景,解决了当前乳腺癌治疗方法的局限性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 乳腺癌是全球领先的健康问题,持续存在治疗挑战.
- 传统疗法的局限性包括耐药性,转移和副作用.
- 纳米酶,具有类似酶活性的纳米材料,提供了新的治疗途径.
研究的目的:
- 审查纳米酶在乳腺癌治疗中的应用.
- 探索纳米酶在改善免疫疗法,化疗和组合疗法的作用.
- 分析纳米酶临床翻译的挑战和前景.
主要方法:
- 在乳腺癌中纳米酶应用的文献综述.
- 对纳米酶机制在调节瘤微环境中的分析.
- 纳米酶在药物输送,抗药克服和综合疗法中的评估.
主要成果:
- 纳米酶可以通过调节瘤微环境和免疫反应来增强免疫疗法.
- 它们通过改善药物输送和克服耐药性来优化化疗.
- 纳米酶促进光热/光动力组合疗法的增强疗效.
结论:
- 纳米酶显示出对精确,高效和低毒性乳腺癌治疗的巨大潜力.
- 解决生物相容性和可扩展性等挑战对于临床翻译至关重要.
- 将纳米酶与现有策略相结合,为乳腺癌治疗提供了有希望的未来方向.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


